Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD)

Analytical and Bioanalytical Chemistry

Volumn 397, Issue 5, 2010, Pages 1809-1819

  Rana, Gaurav S J B ^a   York, Timothy P ^b   Edmiston, Jeffery S ^a   Zedler, Barbara K ^a   Pounds, Joel G ^c   Adkins, Joshua N ^c   Smith, Richard D ^c   Liu, Zaigang ^a   Li, Guoya ^a   Webb, Bradley T ^b   Murrelle, Edward L ^a   Flora, Jason W ^a  

^a Altria Client Services   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Amino acids peptides; Bioanalytical methods; Biological samples; Clinical biomedical analysis; Genomics proteomics

Indexed keywords

ACCURATE MASS; BIOANALYTICAL METHODS; BIOLOGICAL SAMPLES; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CIGARETTE SMOKERS; CIGARETTE SMOKING; CLINICAL/BIOMEDICAL ANALYSIS; FT-ICR MS; HIGH RESOLUTION; HIGH-THROUGHPUT; LUNG FUNCTION; MASS ACCURACY; MISSING DATA; OLDER ADULTS; PROTEIN DATA; PROTEOMES; PROTEOMIC ANALYSIS; PROTEOMIC APPROACHES; STATISTICAL APPROACH; TIME TAG;

COAGULATION; MAGNETIC FIELDS; PEPTIDES; PROBABILITY DISTRIBUTIONS; TOBACCO;

BIOLOGICAL ORGANS;

BIOLOGICAL MARKER; PEPTIDE; PLASMA PROTEIN;

ADULT; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LUNG; LUNG FUNCTION TEST; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; SMOKING;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; LUNG; MALE; MASS SPECTROMETRY; MIDDLE AGED; PEPTIDES; PROSPECTIVE STUDIES; PROTEOMICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 77955681192     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-3742-4     Document Type: Article

References (56)

1. KF Rabe S Hurd A Anzueto PJ Barnes, et al. 2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 532 555 10.1164/rccm.200703-456SO (Pubitemid 47403272)
2. A Lokke P Lange H Scharling P Fabricius, et al. 2006 Developing COPD: a 25 year follow up study of the general population Thorax 61 935 939 10.1136/thx.2006.062802 1:STN:280:DC%2BD28njs1emtA%3D%3D (Pubitemid 44787161)
3. B Lundbäck A Lindberg M Lindström E Rönmark, et al. 2003 Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies Respir Med 97 115 122 10.1053/rmed.2003.1446 (Pubitemid 36284990)
4. D Mannino S Braman 2007 The epidemiology and economics of chronic obstructive pulmonary disease Proc Am Thorac Soc 4 502 506 10.1513/pats.200701- 001FM (Pubitemid 47547843)
5. Z Meng TD Veenstra 2007 Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers Proteomics Clin Appl 1 747 757 10.1002/prca.200700243 1:CAS:528:DC%2BD2sXpvFGgs7c%3D
6. HJ Lee EY Lee MS Kwon YK Paik 2006 Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics Curr Opin Chem Biol 10 42 49 10.1016/j.cbpa.2006.01.007 1:CAS:528:DC%2BD28XhtlGntL8%3D (Pubitemid 43202286)
7. L Pasa-Tolic C Masselon RC Barry Y Shen, et al. 2004 Proteomic analyses using an accurate mass and time tag strategy Biotechniques 37 626 633
8. Anderson KK, Monroe ME, Daly DS (2004) Estimating probabilities of peptide assignments to LC-FTICR-MS observations. In: Valafar F, Valafar H (eds) Proceedings of the international conference on mathematics and engineering techniques in medicine and biological sciences (METMBS '04). CSREA, Las Vegas, pp 151-156
9. RD Smith GA Anderson MS Lipton L Pasa-Tolic, et al. 2002 An accurate mass tag strategy for quantitative and high-throughput proteome measurements Proteomics 2 513 523 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0. CO;2-W 1:CAS:528:DC%2BD38XjslSmuro%3D (Pubitemid 34507341)
10. JN Adkins ME Monroe KJ Auberry Y Shen, et al. 2005 A proteomic study of HUPO's plasma proteome project pilot samples using an accurate mass and time tag strategy Proteomics 5 3454 3466 10.1002/pmic.200401333 1:CAS:528: DC%2BD2MXps12itb0%3D (Pubitemid 41192050)
11. NR Anthonisen JE Connett JP Kiley MD Altose, et al. 1994 Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study JAMA 272 1497 1505 10.1001/jama.272.19.1497 1:STN:280:DyaK2M%2Fls1ejtQ%3D%3D (Pubitemid 24340791)
12. NR Anthonisen JE Connett RP Murray 2002 Smoking and lung function of Lung Health Study participants after 11 years Am J Respir Crit Care Med 166 675 679 10.1164/rccm.2112096 (Pubitemid 34971849)
13. WJ Qian JM Jacobs DG Camp II ME Monroe, et al. 2005 Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry Proteomics 5 572 584 10.1002/pmic.200400942 1:CAS:528:DC%2BD2MXhs1Oiurs%3D (Pubitemid 40262074)
14. ME Belov GA Anderson MA Wingerd HR Udseth, et al. 2004 An automated high performance capillary liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometer for high-throughput proteomics J Am Soc Mass Spectrom 15 212 232 10.1016/j.jasms.2003.09.008 1:CAS:528:DC%2BD2cXptVCgtg%3D%3D (Pubitemid 38183210)
15. JK Eng AL McCormack JR Yates 1994 An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database J Am Soc Mass Spectrom 5 976 989 10.1016/1044-0305(94)80016-2 1:CAS:528: DyaK2MXhvF2htLw%3D
16. AJ Link J Eng DM Schieltz E Carmack, et al. 1999 Direct analysis of protein complexes using mass spectrometry Nat Biotechnol 17 676 682 10.1038/10890 1:CAS:528:DyaK1MXksFehsLc%3D (Pubitemid 29316146)
17. MP Washburn D Wolters JR Yates III 2001 Large-scale analysis of the yeast proteome by multidimensional protein identification technology Nat Biotechnol 19 242 247 10.1038/85686 1:CAS:528:DC%2BD3MXhslaqtbw%3D (Pubitemid 32220565)
18. DM Rocke B Durbin 2001 A model for measurement error for gene expression arrays J Comput Biol 8 557 569 10.1089/106652701753307485 1:CAS:528: DC%2BD3MXpt1Gnsrs%3D (Pubitemid 34053496)
19. EJ van den Oord 2005 Controlling false discoveries in candidate gene studies Mol Psychiatry 10 230 231 10.1038/sj.mp.4001581 (Pubitemid 40432674)
20. Y Benjamini Y Hochberg 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc B 57 289 300
21. JD Storey R Tibshirani 2003 Statistical methods for identifying differentially expressed genes in DNA microarrays Meth Mol Biol 224 149 157 1:CAS:528:DC%2BD3sXjt1yhs7o%3D
22. JD Storey R Tibshirani 2003 Statistical significance for genome-wide studies Proc Natl Acad Sci USA 100 9440 9445 10.1073/pnas.1530509100 1:CAS:528:DC%2BD3sXmtlyktbY%3D (Pubitemid 37033947)
23. M Kanehisa M Araki S Goto M Hattori, et al. 2008 KEGG for linking genomes to life and the environment Nucleic Acids Res 36 D480 D484 10.1093/nar/gkm882 1:CAS:528:DC%2BD1cXhtVSku7k%3D (Pubitemid 351149770)
24. M Kanehisa S Goto M Hattori KF Aoki-Kinoshita, et al. 2006 From genomics to chemical genomics: new developments in KEGG Nucleic Acids Res 34 D354 D357 10.1093/nar/gkj102 1:CAS:528:DC%2BD28XisFyitw%3D%3D
25. M Kanehisa S Goto 2000 KEGG: Kyoto encyclopedia of genes and genomes Nucleic Acids Res 28 27 30 10.1093/nar/28.1.27 1:CAS:528:DC%2BD3cXhvVGqu74%3D
26. GC Donaldson TA Seemungal IS Patel A Bhowmik, et al. 2005 Airway and systemic inflammation and decline in lung function in patients with COPD Chest 128 1995 2004 10.1378/chest.128.4.1995 (Pubitemid 41507533)
27. WQ Gan SF Man A Senthilselvan DD Sin 2004 Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax 59 574 580 10.1136/thx.2003.019588 1:STN:280: DC%2BD2czkslSjsQ%3D%3D (Pubitemid 38901515)
28. JA Wedzicha TA Seemungal PK Maccallum EA Paul, et al. 2000 Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels Thromb Haemost 84 210 215 1:CAS:528:DC%2BD3cXmt1Onsbs%3D
29. MS Bolger DS Ross H Jiang MM Frank, et al. 2007 Complement levels and activity in the normal and LPS-injured lung Am J Physiol Lung Cell Mol Physiol 292 L748 L759 10.1152/ajplung.00127.2006 1:CAS:528:DC%2BD2sXjsFCjsL4%3D (Pubitemid 46376993)
30. MM Markiewski JD Lambris 2007 The role of complement in inflammatory diseases from behind the scenes into the spotlight Am J Pathol 171 715 727 10.2353/ajpath.2007.070166 1:CAS:528:DC%2BD2sXhtV2murjK (Pubitemid 47440971)
31. SI Rennard 1999 Inflammation and repair processes in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 S12 S16 1:STN:280: DC%2BD3c%2FksFSisw%3D%3D
32. BR Celli S Roger 2006 Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance Proc Am Thorac Soc 3 461 465 10.1513/pats.200603-029MS (Pubitemid 44285511)
33. JA Wedzicha TA Seemungal 2007 COPD exacerbations: defining their cause and prevention Lancet 370 786 796 10.1016/S0140-6736(07)61382-8 (Pubitemid 47320802)
34. JR Hurst WR Perera TM Wilkinson GC Donaldson, et al. 2006 Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 173 71 78 10.1164/rccm.200505-704OC 1:CAS:528:DC%2BD28XmslSktrs%3D (Pubitemid 43069790)
35. S Sethi J Maloney L Grove C Wrona, et al. 2006 Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease Am J Respir Crit Care Med 173 991 998 10.1164/rccm.200509-1525OC
36. A Agusti W MacNee K Donaldson M Cosio 2003 Hypothesis: does COPD have an autoimmune component? Thorax 58 832 834 10.1136/thorax.58.10.832 1:STN:280:DC%2BD3svlsVKkuw%3D%3D (Pubitemid 37239227)
37. CA Feghali-Bostwick AS Gadgil LE Otterbein JM Pilewski, et al. 2007 Autoantibodies in patients with COPD Am J Respir Crit Care Med 177 156 163 10.1164/rccm.200701-014OC
38. B Thyagarajan DR Jacobs GG Apostol LJ Smith, et al. 2006 Plasma fibrinogen and lung function: the CARDIA Study Int J Epidemiol 35 1001 1008 10.1093/ije/dyl049 (Pubitemid 44540754)
39. LA Cupples HT Arruda EJ Benjamin RB D'Agostino Sr, et al. 2007 The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports BMC Med Genet 8 S1 10.1186/1471-2350-8- S1-S1 (Pubitemid 351935124)
40. DG Yanbaeva MA Dentener EC Creutzberg G Wesseling, et al. 2007 Systemic effects of smoking Chest 131 1557 1566 10.1378/chest.06-2179 1:CAS:528:DC%2BD2sXmt1Crsr8%3D (Pubitemid 46762366)
41. RE Walter JB Wilk MG Larson RS Vasan, et al. 2008 Systemic inflammation and COPD: the Framingham Heart Study Chest 133 19 25 10.1378/chest.07-0058 1:CAS:528:DC%2BD1cXhslOku7c%3D
42. JE Volanakis 1995 Transcriptional regulation of complement genes Annu Rev Immunol 13 277-305 277 305 10.1146/annurev.iy.13.040195.001425 1:CAS:528:DyaK2MXltFamtbk%3D
43. C Liu Z Xu D Gupta R Dziarski 2001 Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules J Biol Chem 276 34686 34694 10.1074/jbc.M105566200 1:CAS:528:DC%2BD3MXmvFCltLo%3D
44. PS Lee AB Waxman KL Cotich SW Chung, et al. 2007 Plasma gelsolin is a marker and therapeutic agent in animal sepsis Crit Care Med 35 849 855 10.1097/01.CCM.0000253815.26311.24 1:CAS:528:DC%2BD2sXislChtrc%3D (Pubitemid 46407801)
45. M Jourdain O Carrette A Tournoys F Fourrier, et al. 1997 Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation Am J Respir Crit Care Med 156 1825 1833 1:STN:280:DyaK1c%2FnsVSgug%3D%3D
46. B Furie BC Furie 2005 Thrombus formation in vivo J Clin Invest 115 3355 3362 10.1172/JCI26987 1:CAS:528:DC%2BD2MXhtlSqtL3M (Pubitemid 43121819)
47. WP Fay N Garg M Sunkar 2007 Vascular functions of the plasminogen activation system Arterioscler Thromb Vasc Biol 27 1231 1237 10.1161/ATVBAHA.107.140046 1:CAS:528:DC%2BD2sXltl2itbk%3D (Pubitemid 46809410)
48. J Ashitani H Mukae Y Arimura S Matsukura 2002 Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease Intern Med 41 181 185 10.2169/internalmedicine.41.181 1:CAS:528:DC%2BD38XktlWhsLc%3D
49. C Alessandri S Basili F Violi P Ferroni, et al. 1994 Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group Thromb Haemost 72 343 346 1:CAS:528:DyaK2MXis1eqsL4%3D
50. VF Tapson 2005 The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease Proc Am Thorac Soc 2 71 77 10.1513/pats.200407-038MS 1:CAS:528:DC%2BD28XhsFGitrs%3D (Pubitemid 40562966)
51. NF Voelkel CD Cool 2003 Pulmonary vascular involvement in chronic obstructive pulmonary disease Eur Respir J Suppl 46 28s 32s 10.1183/09031936.03. 00000503 1:STN:280:DC%2BD3srjvFOgug%3D%3D
52. L Watson JM Vonk CG Lofdahl NB Pride, et al. 2006 Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study Respir Med 100 746 753 10.1016/j.rmed.2005.08. 004 1:STN:280:DC%2BD287hvVyrsw%3D%3D (Pubitemid 43285764)
53. JB Soriano DD Sin X Zhang PG Camp, et al. 2007 A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo Chest 131 682 689 10.1378/chest.06-1696 (Pubitemid 46446857)
54. JC Hogg 2006 Why does airway inflammation persist after the smoking stops? Thorax 61 96 97 10.1136/thx.2005.049502 1:STN:280: DC%2BD28%2Fot1Siuw%3D%3D (Pubitemid 43235422)
55. A Agusti JB Soriano 2008 COPD as a systemic disease COPD 5 138
56. LM Fabbri F Luppi B Beghe KF Rabe 2008 Complex chronic comorbidities of COPD Eur Respir J 31 204 212 10.1183/09031936.00114307 1:CAS:528: DC%2BD1cXhvVCgsL0%3D